What is the relationship between endometriosis and epithelial ovarian cancer?

CME Journal of Gynecologic Oncology

Volumn 8, Issue 1, 2003, Pages 41-47

  Kelly, Michael G ^a   Pejovic, Tanya ^a   Nezhat, Farr R ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Obstetrics   (United States)

Author keywords

Atypical endometriosis; Clear cell ovarian cancer; Endometrioid ovarian cancer; Endometriosis; Endometriosis associated ovarian cancer; Epithelial ovarian cancer; Hormone replacement therapy

Indexed keywords

ASBESTOS; CYCLINE; CYTOKINE; DNA; ESTROGEN; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; GONADOTROPIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN P53; TALC; UROKINASE; UROKINASE RECEPTOR;

CANCER RISK; CLEAR CELL CARCINOMA; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; INFLAMMATION; MALIGNANT TRANSFORMATION; ONCOGENE; OVARIECTOMY; OVARY CANCER; OVULATION; PATHOGENESIS; PELVIC INFLAMMATORY DISEASE; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0038237360     PISSN: 12199087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Sampson JA. Endometrial carcinoma of the ovary arising in endometrial tissue in that organ. Arch Surg 1925; 10:1-72.
2. Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Nat Cancer Inst 1999; 17(91):1459-1467.
3. Shu XO, Brinton LA, Gao YT, Yuan JM. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 1989; 49:3670-3674.
4. Risch HA, Howe GR. Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomark Prevent 1995; 4:147-151.
5. Parazzini F, LaVecchia C, Negri E, Moroni S, dalPino D, Fedele L. Pelvic inflammatory disease and risk of ovarian cancer. Cancer Epidemiol Biomark Prevent 1996; 5:667-669.
6. Ness RB, Grisso JA, Cottreau C, Klapper J, Vergona R, Wheeler JE, et al. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 2000; 2(11):111-117.
7. Hankinson SE, Hunter DJ, Colditz GA, Willett WC, Stampfer MJ, Rosner B, et al. Tubal ligation, hysterectomy, and risk of ovarian cancer. J Am Med Assoc 1993; 270:2813-2818.
8. Green A, Purdie D, Bain C, Siskind V, Russell P, Quinn M, et al. Tubal sterilisation, hysterectomy, and decreased risk of ovarian cancer. Survery of Women's Health Study Group. Int J Cancer 1997; 71:948-951.
9. Paulson RJ. Fertility drugs and ovarian epithelial cancer: the endometriosis hypothesis. J Assist Reprod Gen 1997; 4(14):228-230.
10. Thomas EJ, Campbell IG. Evidence that endometriosis behaves in a malignant manner. Gynecol Obstet Invest 2000; 50(Suppl):2-10.
11. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997; 176(3):572-579.
12. Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA. Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study. Cancer 2002; 94(5):1612-1618.
13. Vercellini P, Parazzini F, Bolis G, Carinelli S, Dindelli M, Vendola N, et al. Endometriosis and ovarian cancer. Am J Obstet Gynecol 1993; 1(169):181-182.
14. Jimbo H, Yoshikawa H, Onda T, Yasugi T, Sakamoto A, Taketani Y. Prevalence of ovarian endometriosis in epithelial ovarian cancer. Int J Gynecol Obstet 1997; 59:245-250.
15. Chew S, Tham KF, Ratnam SS. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis. Singap Med J 1997; 7(38):289-291.
16. Komiyama S, Aoki D, Tominaga E, Susumu N, Udagawa Y, Nozawa S. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation. Gynecol Onocol 1999; 72:342-346.
17. Scott RB. Malignant changes in endometriosis. Obstet Gynecol 1953; 2:283-289.
18. Sainz De La Cuesta R, Eichhorn JH, Rice LW, Fuller AF, Nikrui N, Goff BA. Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol Oncol 1996; 60:238-244.
19. Prefumo F, Todeschini F, Fulcheri E, Venturini PL. Epithelial abnormalities in cystic ovarian endometriosis. Gynecol Oncol 2002; 84:280-284.
20. LaGrenade A, Silverberg S. Ovarian tumors associated with atypical endometriosis. Hum Pathol 1988; 19:1080-1084.
21. Fukunaga M, Nomura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 1997; 30:249-255.
22. Fishman A, Demirel D, Laucirica R, Ramzy I, Klima T, Lyzak J, et al. Malignant tumors arising in endometriosis: clinical-pathological study and flow cytometry analysis. Eur J Obstet Gynecol 1996; 70:69-74.
23. Ogawa S, Kaku T, Amada S, Kobayashi H, Hirakawa T, Ariyoshi K, et al. Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 2000; 77:298-304.
24. Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol 1990; 75(6):1023-1028.
25. Stern RC, Dash R, Bentley R, Synder MJ, Haney AF, Stanely J. Malignanacy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol 2001; 20(2):133-139.
26. Nishida M, Watanabe K, Sato N, Ichikawa Y. Malignant transformation of ovarian endometriosis. Gynecol Obstet Invest 2000; 50(Suppl):18-25.
27. Baker SJ, Fearson ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989; 244:217-221.
28. Jiang X, Hitchcock A, Bryan EJ, Watson RH, Engelfield P, Thomas EJ, et al. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res 1996; 56:3534-3539.
29. Tamura M, Fukaya T, Murakami T, Uehara S, Tajima A. Analysis of clonality in human endometriotic cysts based on evaluation of X chromosome inactivation in archival formalin-fixed, paraffin-embedded tissue. Lab Invest 1998; 78:213-218.
30. Toki T, Nakayama K. Proliferative activity and genetic alterations in tp53 in endometriosis. Gynecol Obstet Invest 2000; 50(Suppl):33-38.
31. Kobayashi H. Invasive capacity of heterotopic endometrium. Gynecol Obstet Invest 2000; 50(Suppl):26-32.
32. Jiang X, Morland SJ, Hitchcock A, Thomas EJ, Campbell IG. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Cancer Res 1998; 58:1707-1712.
33. Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T. Comparative immunohistochemical studies of bcl-2 an p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer.2002; 94(11):2935-2940.
34. Swiersz LM. Role of endometriosis in cancer and tumor development. Ann NY Acad Sci 2002; 955:281-292.
35. Baxter SW, Thomas EJ, Campbell IG. GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer. Carcinogenesis 2001; 1(22):63-65.
36. Sato N, Tsunoda H, Morishita Y, Takimoto Y, Kubo T, Noguchi M. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene pten in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 2000; 60:7052-7056.
37. Baranova H, Canis M, Ivaschenko T, Albuisson E, Bothorishvilli R, Baranov V, et al. Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases MI and T1 genes in the development of endometriosis. Mol Hum Reprod 1999; 5:636-641.
38. Cramer DW, Greenberg ER, Ttius-Ernstoff, et al. A case-control study of galactose consumption and metabolism in relation to ovarian cancer. Cancer Epidemiol Biomark Prevent 2000; 9:95-101.
39. Morland SJ, Jiang XS, Hitchcock A, Thomas EJ, Campbell IG. Mutation of galactose-1-phosphate uridyl transferase and its association with ovarian cancer and endometriosis. Int J Cancer 1998; 77:825-827.
40. Erzen M, Rakar S, Klancar B, Syrjanen K. Endometriosis-Associated Ovarian Carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Gynecol Oncol 2001; 83:100-108.
41. Grucer F, Pieber D, Arikan MG. Malignancy arising in extraovarian endometriosis during estrogen stimulation. Eur J Gynecol Oncol 1998; 19(1).
42. McCluggage WG, Bryson C, Lamki H, Boyle DD. Benign, borderline and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy. Int J Gynecol Pathol 2000; 19(3):276-279.
43. Cohen I, Altaras MM, Lew S, Trepper R, Beyth Y, Ben-Baruch. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature. Gynecol Oncol 1994; 55:443-447.
44. Dangel A, Medchill MT, Davis G, Meloni AM, Sandberg AA. Cytogenetic studies in endometriosis tissue. Cancer Gen Cytogen; 78(2), 172-174.
45. Erzen M, Kovacic J. Relationship between endometriosis and ovarian cancer. Eur J Gyneocol Onocol 1998; 19(6).
46. Fukunaga M, Ushigome S. Epithelial metaplastic changes in ovarian endometriosis. Modern Pathol 1998; 11(8):784-788.